The importance of ROS in KRAS-mediated tumorigenesis is further corroborated by the fact that the mitochondria-targeted drugs Mito-CP (carboxy proxyl nitroxide) and Mito-Metformin block the proliferation of colon cancer cells.128. Here, KRAS is linked to malignant colon neoplasm.